BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 36980271)

  • 1. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
    Silva-Pedrosa R; Salgado AJ; Ferreira PE
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond.
    Liu C; Oikonomopoulos A; Sayed N; Wu JC
    Development; 2018 Mar; 145(5):. PubMed ID: 29519889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Organoids-Challenges to Establish a Brain Prototype.
    Eremeev AV; Lebedeva OS; Bogomiakova ME; Lagarkova MA; Bogomazova AN
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids: Modelling and Therapy of Neurodegenerative Diseases.
    Bordoni M; Rey F; Fantini V; Pansarasa O; Di Giulio AM; Carelli S; Cereda C
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age.
    Grenier K; Kao J; Diamandis P
    Mol Psychiatry; 2020 Feb; 25(2):254-274. PubMed ID: 31444473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
    Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
    Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iPSCs-Based Neural 3D Systems: A Multidimensional Approach for Disease Modeling and Drug Discovery.
    Costamagna G; Andreoli L; Corti S; Faravelli I
    Cells; 2019 Nov; 8(11):. PubMed ID: 31739555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Culture of Human-Induced Pluripotent Stem Cell-Derived Cerebral Organoid Cells.
    Yan Y; Arzua T; Logan S; Bai X
    Methods Mol Biol; 2022; 2454():483-494. PubMed ID: 33029748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Forebrain Organoids from Induced Pluripotent Stem Cells: A Novel Approach to Model Repair of Ionizing Radiation-Induced DNA Damage in Human Neurons.
    Das D; Li J; Cheng L; Franco S; Mahairaki V
    Radiat Res; 2020 Aug; 194(2):191-198. PubMed ID: 32845994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of organoids for personalized medicine.
    Perkhofer L; Frappart PO; Müller M; Kleger A
    Per Med; 2018 Nov; 15(6):461-465. PubMed ID: 30418092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells, organoids and their applications for human diseases: Special issue of BMB Reports in 2023.
    Shin K
    BMB Rep; 2023 Jan; 56(1):1. PubMed ID: 36698280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Cytomegalovirus Compromises Development of Cerebral Organoids.
    Brown RM; Rana PSJB; Jaeger HK; O'Dowd JM; Balemba OB; Fortunato EA
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31217239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of iPSC-Derived Brain Organoids for Drug Testing and Toxicological Evaluation.
    Nguyen HN
    Methods Mol Biol; 2022; 2474():93-105. PubMed ID: 35294759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling amyloid beta and tau pathology in human cerebral organoids.
    Gonzalez C; Armijo E; Bravo-Alegria J; Becerra-Calixto A; Mays CE; Soto C
    Mol Psychiatry; 2018 Dec; 23(12):2363-2374. PubMed ID: 30171212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling cell-cell interactions in the brain using cerebral organoids.
    Oliveira B; Çerağ Yahya A; Novarino G
    Brain Res; 2019 Dec; 1724():146458. PubMed ID: 31521639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
    Nam KH; Yi SA; Jang HJ; Han JW; Lee J
    Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emergence of Stem Cell-Based Brain Organoids: Trends and Challenges.
    Gopalakrishnan J
    Bioessays; 2019 Aug; 41(8):e1900011. PubMed ID: 31274205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
    Fan W; Sun Y; Shi Z; Wang H; Deng J
    Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.